2-(1,3-Benzothiazol-2-yl)-1-phenylethan-1-one, 97%, 1g

N,N-Dimethylethylamine>98.0%(GC)(T)25mL

(1S,4S)-2-Benzyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide, 95.0%, 10g

(S)-benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, 97%, 100mg

(E)-3-(4-pentylphenyl)but-2-enoic acid, 98%, 1g

(S)-1-Methylpiperidine-3-carboxylic acid, 95.0%, 1g

Triisopropyl((6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)silane, 97%, 5g

(3-(Piperidin-1-yl)phenyl)boronic acid, 97.0%, 1g

2,4-Dichloro-5-cyanothiazole, 95.0%, 10g

3-methyl-1-oxa-3,8-diazaspiro[4.6]undecan-2-one, 95.0%, 250mg

3-BROMO-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE HCL, 95.0%, 500mg

1H-Indole-6-carbaldehyde, 97.0%, 5g

ethyl 4-oxo-4-(3,4,5-trifluorophenyl)butyrate, 97.0%, 2g